Expert Review of Pharmacoeconomics & Outcomes Research
Scope & Guideline
Unlocking the Value of Pharmacoeconomics for Healthcare Progress
Introduction
Aims and Scopes
- Pharmacoeconomics:
The journal publishes comprehensive analyses of the economic aspects of drug therapies, including cost-effectiveness and budget impact analyses, to inform healthcare decision-making. - Health Technology Assessment (HTA):
Research on the methodologies and applications of HTA in evaluating the value of new health technologies, drugs, and interventions to guide policy and reimbursement decisions. - Patient-reported Outcomes:
Studies focusing on measuring and valuing health-related quality of life and patient-reported outcomes, which are critical for assessing the impact of treatments from the patient's perspective. - Comparative Effectiveness Research:
Analysis comparing the effectiveness, safety, and cost of different therapeutic interventions to provide evidence for clinical guidelines and policy-making. - Digital Health and Innovation:
Exploration of the economic implications of digital health technologies and innovations, including their role in improving medication adherence and patient outcomes. - Global Health Economics:
Research addressing pharmacoeconomic evaluations in various global contexts, particularly in low- and middle-income countries, to understand the broader implications of healthcare interventions.
Trending and Emerging
- Integration of Machine Learning and AI:
There is a growing trend towards utilizing machine learning and artificial intelligence in health economic evaluations, offering novel approaches to predict outcomes and enhance decision-making. - Value-Based Healthcare Models:
An increased focus on value-based healthcare, with research exploring how to align reimbursement models with patient outcomes and overall healthcare value. - Real-World Evidence (RWE):
The importance of real-world evidence is gaining traction, with studies emphasizing the need to assess the effectiveness and economic impact of interventions in everyday clinical settings. - Patient Engagement in Research:
Emerging themes include the engagement of patients in the development of health economic evaluations, emphasizing the importance of incorporating patient preferences and experiences. - Sustainability and Environmental Considerations:
A new focus on incorporating sustainability metrics into health economic evaluations, addressing the environmental impact of healthcare interventions. - Cross-Disciplinary Approaches:
An increase in interdisciplinary research that combines insights from economics, public health, and clinical practice to address complex healthcare challenges.
Declining or Waning
- Traditional Cost-Utility Analyses:
There is a noticeable decline in studies solely relying on traditional cost-utility analyses without integrating broader health economic perspectives or real-world evidence. - Focus on Localized Studies:
The emphasis on localized pharmacoeconomic studies is decreasing, with a shift towards more globally relevant research that can inform international health policies. - Single Disease Focus:
Research concentrating on singular diseases is becoming less common, as the journal increasingly favors studies that incorporate multi-condition perspectives or address comorbidities. - Outdated Methodologies:
There is a decline in the publication of studies utilizing outdated economic evaluation methodologies, as the field evolves towards more sophisticated and innovative approaches. - Static Policy Evaluations:
Research that merely evaluates existing policies without proposing actionable insights or innovations is becoming less prevalent, reflecting a need for more dynamic and forward-thinking analyses.
Similar Journals
Journal of Pharmaceutical Health Services Research
Shaping the future of health services through rigorous research.Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.
Applied Health Economics and Health Policy
Bridging economic theory and health policy for a healthier future.Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.
Pharmacoeconomics-Open
Transforming Healthcare Through Collaborative ScholarshipPharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.
Journal of Comparative Effectiveness Research
Connecting research to practice for better health solutions.Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.
Value in Health Regional Issues
Connecting Economics and Health Outcomes for a Better Tomorrow.Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.
Research in Social & Administrative Pharmacy
Elevating pharmacy practice through rigorous academic exploration.Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.
British Journal of Surgery
Shaping the landscape of modern surgery.The British Journal of Surgery, published by OXFORD UNIV PRESS, stands as a preeminent periodical in the field of surgery, as evidenced by its impressive impact factor and esteemed ranking of #7 out of 551 in the Scopus category of Medicine - Surgery, placing it in the 98th percentile. Since its inception in 1913, the journal has dedicated itself to disseminating cutting-edge research, innovative surgical techniques, and comprehensive meta-analyses, thereby shaping the future of surgical practice and education. With a robust commitment to academic rigor, it has consistently maintained a prestigious position in the Q1 category of surgery as of 2023, affirming its relevance in the modern medical landscape. The journal provides essential access to healthcare professionals, researchers, and students passionate about advancing surgical knowledge and improving patient outcomes. Operated from its headquarters in Oxford, United Kingdom, the British Journal of Surgery is pivotal for anyone looking to stay at the forefront of surgical advancements.
Journal of Health Economics and Outcomes Research
Bridging the gap between health economics and policy.Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.
MEDICAL DECISION MAKING
Transforming theory into practice for healthcare excellence.Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.
International Journal of Health Economics and Management
Bridging health policy and economic strategy for better outcomes.International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.